Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.21.2
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Schedule of the grant date value of the options granted
For the Three Months Ended For the Nine Months Ended
September 30, September 30,
2021 2020 2021 2020
Risk free interest rate 1.01 % 0.55% - 0.69 % 1.01% - 1.58 % 0.55% - 0.69 %
Expected term (years) 6.25 6.25 6.25 6.25
Expected volatility 46 % 38 % 40% - 46 % 38 %
Expected dividends 0.00 % 0.00 % 0.00 % 0.00 %

Schedule of option activity
Weighted Weighted
Average Average
Number of Exercise Remaining Intrinsic
Options Price Term (Yrs) Value
Outstanding, January 1, 2021 2,430,000 $ 4.15
Granted 360,000 2.33
Exercised
-
-
Expired
-
-
Forfeited (225,000 ) 4.51
Outstanding, September 30, 2021 2,565,000 $ 3.88 6.76 $
-
Exercisable, September 30, 2021 1,360,000 $ 4.09 4.79 $
-

Schedule of options outstanding and exercisable
Options Outstanding Options Exercisable
Weighted
Outstanding Average Exercisable
Exercise Number of Remaining Life Number of
Price Options In Years Options
$ 2.11 80,000 8.75 20,000
$ 2.17 120,000 8.85 120,000
$ 2.21 200,000
-
-
$ 2.48 160,000
-
-
$ 4.09 1,725,000 3.74 1,050,000
$ 5.66 280,000 7.97 170,000
2,565,000 4.79 1,360,000

Schedule of non-vested restricted stock activity
Weighted
Number of Average
Restricted Grant Date
Stock Fair Value
Non-vested balance, January 1, 2021 199,143 $ 2.03
Granted 80,000 2.00
Vested (174,143 ) 1.69
Forfeited (25,000 ) 2.17
Non-vested balance, September 30, 2021 80,000 $ 2.00